Market Samachar
Home  ›  GLOBAL
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
GURUFOCUS.COM · GLOBAL ·

SYRE Maintained by Wedbush -- Price Target Lowered to $123.00

As reported by gurufocus.com
Spyre Therapeutics SYRE Analyst Rating Update On August 26, 2026, Wedbush maintained an "Outperform" rating for Spyre Therapeutics Inc (SYRE) while adjusting i...
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on gurufocus.com ↗

Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar